Weekly compared with daily blood glucose monitoring in women with diet-treated gestational diabetes

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Objective: To estimate whether daily blood glucose self-monitoring reduces macrosomia when compared with weekly office testing in women with gestational diabetes. Methods: Between January 1991 and December 1997, standard treatment at our hospital for women with diet-treated gestational diabetes included routine office monitoring of fasting blood glucose. Beginning in January 1998, blood glucose self-monitoring (four times daily) became the standard management. Women with diet-treated gestational diabetes who underwent routine office-based monitoring of fasting glucose values were compared with similar women who used blood glucose self-monitoring. The outcomes of interest were birthweight at or above 4,000 g and large for gestational age (LGA) in relation to the method of blood glucose self-monitoring. Results: A total of 315 women used daily blood glucose self-monitoring, and they were compared with 675 women with weekly office-based glucose testing. Women with daily blood glucose self-monitoring had fewer macrosomic (29.5% compared with 21.9%, P=.013) and LGA neonates (34.4% compared with 23.1%, P≤.001) and gained significantly less weight (median 0.56, interquartile range 0.22-1.08 lb per week compared with 0.74, interquartile range 0.33-1.17 lb per week, P=.009). Conclusion: Daily blood glucose self-monitoring, compared with weekly office-based testing, is associated with a reduction in the incidence of macrosomia.

Original languageEnglish (US)
Pages (from-to)1307-1312
Number of pages6
JournalObstetrics and Gynecology
Volume113
Issue number6
DOIs
StatePublished - Jun 1 2009

Fingerprint

Blood Glucose Self-Monitoring
Gestational Diabetes
Blood Glucose
Diet
Gestational Age
Fasting
Glucose
Newborn Infant
Weights and Measures
Incidence

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Weekly compared with daily blood glucose monitoring in women with diet-treated gestational diabetes. / Hawkins, J. Seth; Casey, Brian M.; Lo, Julie Y.; Moss, Kristie; McIntire, Donald D.; Leveno, Kenneth J.

In: Obstetrics and Gynecology, Vol. 113, No. 6, 01.06.2009, p. 1307-1312.

Research output: Contribution to journalArticle

@article{e2fd7c40507b41a790dd7a9521f1a6b3,
title = "Weekly compared with daily blood glucose monitoring in women with diet-treated gestational diabetes",
abstract = "Objective: To estimate whether daily blood glucose self-monitoring reduces macrosomia when compared with weekly office testing in women with gestational diabetes. Methods: Between January 1991 and December 1997, standard treatment at our hospital for women with diet-treated gestational diabetes included routine office monitoring of fasting blood glucose. Beginning in January 1998, blood glucose self-monitoring (four times daily) became the standard management. Women with diet-treated gestational diabetes who underwent routine office-based monitoring of fasting glucose values were compared with similar women who used blood glucose self-monitoring. The outcomes of interest were birthweight at or above 4,000 g and large for gestational age (LGA) in relation to the method of blood glucose self-monitoring. Results: A total of 315 women used daily blood glucose self-monitoring, and they were compared with 675 women with weekly office-based glucose testing. Women with daily blood glucose self-monitoring had fewer macrosomic (29.5{\%} compared with 21.9{\%}, P=.013) and LGA neonates (34.4{\%} compared with 23.1{\%}, P≤.001) and gained significantly less weight (median 0.56, interquartile range 0.22-1.08 lb per week compared with 0.74, interquartile range 0.33-1.17 lb per week, P=.009). Conclusion: Daily blood glucose self-monitoring, compared with weekly office-based testing, is associated with a reduction in the incidence of macrosomia.",
author = "Hawkins, {J. Seth} and Casey, {Brian M.} and Lo, {Julie Y.} and Kristie Moss and McIntire, {Donald D.} and Leveno, {Kenneth J.}",
year = "2009",
month = "6",
day = "1",
doi = "10.1097/AOG.0b013e3181a45a93",
language = "English (US)",
volume = "113",
pages = "1307--1312",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Weekly compared with daily blood glucose monitoring in women with diet-treated gestational diabetes

AU - Hawkins, J. Seth

AU - Casey, Brian M.

AU - Lo, Julie Y.

AU - Moss, Kristie

AU - McIntire, Donald D.

AU - Leveno, Kenneth J.

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Objective: To estimate whether daily blood glucose self-monitoring reduces macrosomia when compared with weekly office testing in women with gestational diabetes. Methods: Between January 1991 and December 1997, standard treatment at our hospital for women with diet-treated gestational diabetes included routine office monitoring of fasting blood glucose. Beginning in January 1998, blood glucose self-monitoring (four times daily) became the standard management. Women with diet-treated gestational diabetes who underwent routine office-based monitoring of fasting glucose values were compared with similar women who used blood glucose self-monitoring. The outcomes of interest were birthweight at or above 4,000 g and large for gestational age (LGA) in relation to the method of blood glucose self-monitoring. Results: A total of 315 women used daily blood glucose self-monitoring, and they were compared with 675 women with weekly office-based glucose testing. Women with daily blood glucose self-monitoring had fewer macrosomic (29.5% compared with 21.9%, P=.013) and LGA neonates (34.4% compared with 23.1%, P≤.001) and gained significantly less weight (median 0.56, interquartile range 0.22-1.08 lb per week compared with 0.74, interquartile range 0.33-1.17 lb per week, P=.009). Conclusion: Daily blood glucose self-monitoring, compared with weekly office-based testing, is associated with a reduction in the incidence of macrosomia.

AB - Objective: To estimate whether daily blood glucose self-monitoring reduces macrosomia when compared with weekly office testing in women with gestational diabetes. Methods: Between January 1991 and December 1997, standard treatment at our hospital for women with diet-treated gestational diabetes included routine office monitoring of fasting blood glucose. Beginning in January 1998, blood glucose self-monitoring (four times daily) became the standard management. Women with diet-treated gestational diabetes who underwent routine office-based monitoring of fasting glucose values were compared with similar women who used blood glucose self-monitoring. The outcomes of interest were birthweight at or above 4,000 g and large for gestational age (LGA) in relation to the method of blood glucose self-monitoring. Results: A total of 315 women used daily blood glucose self-monitoring, and they were compared with 675 women with weekly office-based glucose testing. Women with daily blood glucose self-monitoring had fewer macrosomic (29.5% compared with 21.9%, P=.013) and LGA neonates (34.4% compared with 23.1%, P≤.001) and gained significantly less weight (median 0.56, interquartile range 0.22-1.08 lb per week compared with 0.74, interquartile range 0.33-1.17 lb per week, P=.009). Conclusion: Daily blood glucose self-monitoring, compared with weekly office-based testing, is associated with a reduction in the incidence of macrosomia.

UR - http://www.scopus.com/inward/record.url?scp=67649388380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649388380&partnerID=8YFLogxK

U2 - 10.1097/AOG.0b013e3181a45a93

DO - 10.1097/AOG.0b013e3181a45a93

M3 - Article

C2 - 19461427

AN - SCOPUS:67649388380

VL - 113

SP - 1307

EP - 1312

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 6

ER -